The Nootropics Market is Predict to reach USD 13.31 Billion by 2032, at a CAGR of 14.3%

Nootropics Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Nootropics Market size is expected to reach $13.31 billion by 2032, rising at a market growth of 14.3% CAGR during the forecast period.

The modern culture of productivity, coupled with the growing awareness of cognitive health, is another key factor driving nootropic adoption. Consumers are seeking ways to optimize their cognitive abilities to perform better at work or school and to prolong mental sharpness and quality of life as they age. The desire for improved mental clarity and performance is gradually becoming a major cultural trend, contributing to the rising acceptance and use of nootropics.

The Offline segment led the maximum revenue in the Global Nootropics Market by Distribution Channel in 2024, thereby, achieving a market value of $9.4 billion by 2032. This dominance was primarily driven by consumer preference for in-store purchases, especially in pharmacies, health stores, and supermarkets, where they can access professional guidance and physically evaluate products before buying. Trust in brick-and-mortar outlets, immediate product availability, and personalized customer service further contributed to the segment’s strong performance.

The Capsules & Tablets segment is growing at a CAGR of 13.9 % during the forecast period. This form gained popularity due to its convenience, precise dosage, and ease of consumption, making it a preferred choice among consumers seeking cognitive enhancement. The extended shelf life, portability, and availability of a wide range of capsule and tablet-based formulations from established and emerging brands further strengthened this segment’s market position.

Full Report: https://www.kbvresearch.com/nootropics-market/

The North America region dominated the Global Nootropics Market by Region in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $5.0 billion by 2032. The Europe region is anticipated to grow at a CAGR of 13.9% during (2025 - 2032). Additionally, The Asia Pacific region would witness a CAGR of 15.2% during (2025 - 2032).

List of Key Companies Profiled

• Onnit Labs, Inc.
• Reckitt Benckiser Group PLC
• Natural Stacks
• Mind Lab Pro (Opti-Nutra, ltd.)
• PowderCity.com,Ltd
• NOW Foods, Inc.
• Purelife Bioscience Co., Ltd.
• Peak Nootropics
• AlternaScript
• Teva Pharmaceutical Industries Ltd.

Nootropics Market Report Segmentation

By Distribution Channel

• Offline
• Online

By Form

• Capsules & Tablets
• Powder
• Drinks
• Other Form

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports: